American Association for Cancer Research
00085472can120614-sup-f6_f7_536k.pdf (536.31 kB)

Supplementary Figures 6 and 7 from OTX2 Represses Myogenic and Neuronal Differentiation in Medulloblastoma Cells

Download (536.31 kB)
journal contribution
posted on 2023-03-30, 21:07 authored by Ren-Yuan Bai, Verena Staedtke, Hart G. Lidov, Charles G. Eberhart, Gregory J. Riggins

PDF file, 536K, S6:Cytogenetic features of myogenic cells in MMB #1 and #2; S7:Higher concentrations of doxycycline inhibit myogenesis.



The brain development transcription factor OTX2 is overexpressed and/or genomically amplified in most medulloblastomas, but the mechanistic basis for its contributions in this setting are not understood. In this study, we identified OTX2 as a transcriptional repressor and a gatekeeper of myogenic and neuronal differentiation in medulloblastoma cells. OTX2 binds to the MyoD1 core enhancer through its homeobox domain, and the remarkable repressor activity exhibited by the homeobox domain renders OTX2 transcriptionally repressive. RNA interference–mediated attenuation of OTX2 expression triggered myogenic and neuronal differentiation in vitro and prolonged the survival in an orthotopic medulloblastoma mouse model. Conversely, inducing myogenic conversion of medulloblastoma cells led to the loss of OTX2 expression. In medullomyoblastoma, a medulloblastoma subtype containing muscle elements, myogenic cells share cytogenetic signatures with the primitive tumor cells and OTX2 expression was lost in the differentiated myogenic cells. Thus, OTX2 functions via its homeobox domain as a suppressor of differentiation, and the loss of OTX2 expression is linked to the myogenesis in medullomyoblastoma. Together, our findings illustrate the origin of muscle cells in medullomyoblastomas and the oncogenic mechanism of OTX2 as a repressor of diverse differentiating potential. Cancer Res; 72(22); 5988–6001. ©2012 AACR.